Literature DB >> 8597269

Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid.

M Kamei1, Y Tano, T Maeno, Y Ikuno, H Mitsuda, T Yuasa.   

Abstract

PURPOSE: To assess the result of surgical removal of submacular hemorrhage by using tissue plasminogen activator and perfluorocarbon liquid.
METHODS: In 22 consecutive patients (22 eyes), subretinal hemorrhage associated with age-related macular degeneration, which involved the fovea and completely obscured the choroidal vascular pattern, was treated by pars plana vitrectomy. The hemorrhages were liquefied with tissue plasminogen activator, squeezed into the vitreous cavity with perfluorocarbon liquid, and then evacuated.
RESULTS: Efficacy of the procedure was judged by the best postoperative corrected visual acuity, which was 20/100 or better in 16 eyes (73%). Submacular hemorrhage recurred in four (18%) eyes, epiretinal membrane formed in three (14%) eyes, and retinal detachment occurred in three (14%) eyes. Best-corrected final visual acuity was improved postoperatively in 18 (82%) of the 22 eyes, unchanged in three (14%) eyes, and decreased in one (5%) eye, final visual acuity was 20/200 or better in 15 eyes (68%) and limited in other eyes by subretinal hemorrhage of greater than 30 days' duration or subfoveal neovascularizations.
CONCLUSIONS: Use of tissue plasminogen activator and perfluorocarbon liquid in surgical removal of submacular hemorrhage may improve the outcome of surgery by reducing surgically induced retinal damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8597269     DOI: 10.1016/s0002-9394(14)70274-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  28 in total

1.  Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results.

Authors:  Alexandra Lappas; Andreas M H Foerster; Andreas W A Weinberger; Silke Coburger; Norbert F Schrage; Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-06       Impact factor: 3.117

2.  Scanning and transmission electron microscopic findings during RPE wound healing in vivo.

Authors:  A Oganesian; E Bueno; Q Yan; C Spee; J Black; N A Rao; P F Lopez
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

3.  [Subretinal surgery for massive hemorrhage].

Authors:  P Szurman
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage.

Authors:  Y Oshima; M Ohji; Y Tano
Journal:  Br J Ophthalmol       Date:  2006-08-17       Impact factor: 4.638

5.  Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularization.

Authors:  Ikuko Kachi; Tsutomu Yasukawa; Aki Kato; Noriaki Takase; Hiroshi Morita; Ayae Kubota; Yoshio Hirano; Akiyoshi Uemura; Yuichiro Ogura
Journal:  Jpn J Ophthalmol       Date:  2016-02-26       Impact factor: 2.447

6.  Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.

Authors:  Takeshi Mizutani; Tsutomu Yasukawa; Yuya Ito; Ayae Takase; Yoshio Hirano; Munenori Yoshida; Yuichiro Ogura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-29       Impact factor: 3.117

7.  Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration.

Authors:  Naoko Ueda-Arakawa; Akitaka Tsujikawa; Kenji Yamashiro; Sotaro Ooto; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2012-10-04       Impact factor: 2.447

8.  Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.

Authors:  John T Thompson; Raymond N Sjaarda
Journal:  Trans Am Ophthalmol Soc       Date:  2005

9.  Treatment of massive subretinal hematoma associated with age-related macular degeneration using vitrectomy with intentional giant tear.

Authors:  Eisuke Isizaki; Seita Morishita; Takaki Sato; Masanori Fukumoto; Hiroyuki Suzuki; Teruyo Kida; Mari Ueki; Tsunehiko Ikeda
Journal:  Int Ophthalmol       Date:  2015-07-28       Impact factor: 2.031

10.  Management of postvitrectomy diabetic vitreous hemorrhage with volume homeostatic fluid-fluid exchanger.

Authors:  Wen-Chuan Wu; Jen-Yu Chen; Ya-Chi Chen; Yo-Chen Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.